12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
周一盘前交易时段，12只医疗保健股走势
Gainers
获胜者
- Vistagen Therapeutics (NASDAQ:VTGN) stock increased by 187.5% to $4.83 during Monday's pre-market session. The market value of their outstanding shares is at $38.5 million.
- Nektar Therapeutics (NASDAQ:NKTR) stock moved upwards by 33.87% to $0.71. The company's market cap stands at $134.9 million.
- Tabula Rasa HealthCare (NASDAQ:TRHC) stock increased by 32.05% to $10.34. The market value of their outstanding shares is at $277.6 million. The company's, Q2 earnings came out today.
- T2 Biosystems (NASDAQ:TTOO) stock moved upwards by 25.92% to $0.31. The market value of their outstanding shares is at $91.3 million. As per the press release, Q2 earnings came out today.
- Gracell Biotechnologies (NASDAQ:GRCL) shares rose 17.25% to $4.01. The market value of their outstanding shares is at $271.5 million.
- Protalix BioTherapeutics (AMEX:PLX) shares rose 16.25% to $1.93. The market value of their outstanding shares is at $138.1 million. The company's, Q2 earnings came out today.
- 维斯塔根 Therapeutics 纳斯达克股票代码：VTGN）股价在周一的盘前交易中上涨了187.5％，至4.83美元。他们已发行股票的市值为3,850万美元。
- Nektar 疗法 纳斯达克股票代码：NKTR）股价上涨33.87％，至0.71美元。该公司的市值为1.349亿美元。
- 塔布拉·拉萨医疗保健 纳斯达克股票代码：TRHC）的股票上涨了32.05％，至10.34美元。他们已发行股票的市值为2.776亿美元。该公司第二季度财报于今天公布。
- T2 生物系统 纳斯达克股票代码：TTOO）股价上涨25.92％，至0.31美元。他们已发行股票的市值为9,130万美元。根据新闻稿，第二季度财报于今天公布。
- 格雷塞尔生物科技 纳斯达克股票代码：GRCL）股价上涨17.25％，至4.01美元。他们已发行股票的市值为2.715亿美元。
- Protalix Biotherape (AMEX: PLX) 股价上涨16.25％，至1.93美元。他们已发行股票的市值为1.381亿美元。该公司第二季度财报于今天公布。
Losers
失败者
- Sage Therapeutics (NASDAQ:SAGE) stock declined by 48.5% to $18.6 during Monday's pre-market session. The company's market cap stands at $1.1 billion. As per the press release, Q2 earnings came out today.
- Tivic Health Systems (NASDAQ:TIVC) stock declined by 40.17% to $0.04. The company's market cap stands at $4.8 million.
- Aceragen (NASDAQ:ACGN) stock declined by 30.3% to $0.52. The company's market cap stands at $4.3 million.
- Quantum-Si (NASDAQ:QSI) shares decreased by 25.08% to $2.54. The company's market cap stands at $359.4 million. As per the press release, Q2 earnings came out today.
- Apellis Pharmaceuticals (NASDAQ:APLS) shares declined by 15.41% to $20.75. The market value of their outstanding shares is at $2.4 billion.
- HUTCHMED (China) (NASDAQ:HCM) shares declined by 13.6% to $14.24. The company's market cap stands at $2.4 billion. See Also:
- 鼠尾草疗法 纳斯达克股票代码：SAGE）股价在周一的盘前交易时段下跌了48.5％，至18.6美元。该公司的市值为11亿美元。根据新闻稿，第二季度财报于今天公布。
- Tivic 健康系统 纳斯达克股票代码：TIVC）股价下跌40.17％，至0.04美元。该公司的市值为480万美元。
- Aceragen 纳斯达克股票代码：ACGN）股价下跌30.3％，至0.52美元。该公司的市值为430万美元。
- Quantum-Si 纳斯达克股票代码：QSI）股价下跌25.08％，至2.54美元。该公司的市值为3.594亿美元。根据新闻稿，第二季度财报于今天公布。
- 阿佩利斯制药 纳斯达克股票代码：APLS）股价下跌15.41％，至20.75美元。他们已发行股票的市值为24亿美元。
- 和黄医药（中国） 纳斯达克股票代码：HCM）股价下跌13.6％，至14.24美元。该公司的市值为24亿美元。 另请参阅：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。